☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ocular hypertension
Aerie's Rhokiinsa (netarsudil ophthalmic solution- 0.02%) Receives EC's Approval for Patients with Open-Angle Glaucoma or Ocular H...
November 21, 2019
Allergan Reports FDA's Acceptance of NDA for Bimatoprost Sustained-Release to Treat Glaucoma or Ocular Hypertension
July 17, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
